13F-HR filed by Boxer Capital Management, LLC
Boxer Capital Management, LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:30:08 UTC, with 47 holding rows worth $1,150,652,180.
- Accession
- 0001213900-26-120704
- Filer
- CIK 2018299
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 47 entries on the cover page, a total value of $1,150,652,180 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,150,652,180 with VALUE read as dollars as filed, 13F file number 028-25329. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| TANGO THERAPEUTICS INC | 87583X109 | COM | 10,526,219 | $262,629,164 | dollars as filed | |
| KODIAK SCIENCES INC | 50015M109 | COM | 1,477,600 | $140,076,480 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 500,000 | $102,630,000 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 524,551 | $58,639,556 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 4,278,159 | $56,642,825 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 474,971 | $47,031,628 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 1,360,683 | $43,786,778 | dollars as filed | |
| CORCEPT THERAPEUTICS INC | 218352102 | COM | 335,500 | $38,659,665 | dollars as filed | |
| PRECIGEN INC | 74017N105 | COM | 4,320,339 | $36,982,101 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 1,423,243 | $34,385,550 | dollars as filed | |
| DEFINIUM THERAPEUTICS INC | 24477V105 | COM SHS | 683,615 | $26,018,386 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 893,153 | $25,990,752 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 283,054 | $25,200,297 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 170,000 | $23,951,300 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 286,239 | $22,761,725 | dollars as filed | |
| OPUS GENETICS INC | 67577R102 | COMMON STOCK | 4,533,660 | $21,942,914 | dollars as filed | |
| Q32 BIO INC | 746964105 | Common Stock | 2,577,642 | $21,317,099 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 500,000 | $20,315,000 | dollars as filed | |
| ACHIEVE LIFE SCIENCES INC | 004468500 | COMMON STOCK | 2,150,000 | $17,393,500 | dollars as filed | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 4,150,000 | $13,819,500 | dollars as filed | |
| FIRST TRACKS BIOTHERAPEUTICS | 337185102 | ORD SHS *A* | 240,000 | $8,505,600 | dollars as filed | |
| SHATTUCK LABS INC | 82024L103 | COMMON STOCK | 1,175,396 | $8,016,200 | dollars as filed | |
| SAB BIOTHERAPEUTICS INC | 78397T202 | COMMON STOCK | 2,500,000 | $7,925,000 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 450,000 | $6,907,500 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 494,000 | $6,629,480 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 100,000 | $6,591,000 | dollars as filed | |
| PALISADE BIO INC | 696389402 | COMMON STOCK | 4,799,875 | $6,479,831 | dollars as filed | |
| CAPRICOR THERAPEUTICS INC | 14070B309 | COMMON STOCK | 642,837 | $6,087,666 | dollars as filed | |
| Electra Therapeutics, Inc. | 284825106 | Common Stock, $0.0001 par value per share | 450,000 | $5,062,500 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 944,035 | $5,022,266 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 175,465 | $4,769,138 | dollars as filed | |
| EDESA BIOTECH INC | 27966L306 | COM NEW | 937,363 | $3,946,298 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 200,000 | $3,610,000 | dollars as filed | |
| KAZIA THERAPEUTICS LTD | 48669G303 | SPONSORED ADS | 371,500 | $3,564,542 | dollars as filed | |
| ATTOVIA THERAPEUTICS INC | 04987L102 | COM | 200,000 | $3,428,000 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 2,050,000 | $3,423,500 | dollars as filed | |
| CRESCENT BIOPHARMA INC. | 38000Q201 | COM | 226,843 | $3,309,639 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 1,013,555 | $2,807,547 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 150,000 | $2,733,000 | dollars as filed | |
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 1,500,000 | $2,400,000 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 100,000 | $2,371,000 | dollars as filed | |
| SIONNA THERAPEUTICS INC | 829401108 | COMMON STOCK | 391,723 | $2,060,462 | dollars as filed | |
| CLENE INC | 185634201 | COM NEW | 477,515 | $1,948,261 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 300,000 | $1,578,000 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 666,666 | $577,132 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 954,052 | $568,805 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U205 | COMMON STOCK | 127,536 | $155,593 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001213900-26-120704 | this filing | 2026-11-16 |